BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for I Moreno

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis of new derivatives of 21-imidazolyl-16-dehydropregnenolone as inhibitors of 5a-reductase 2 and with cytotoxic activity in cancer cells.EBI
Universidad Nacional Aut£Noma De M£Xico
Biphenyl Pyridazinone Derivatives as Inhaled PDE4 Inhibitors: Structural Biology and Structure-Activity Relationships.EBI
RhôNe-Poulenc Rorer
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: the role of a hydrogen-bond acceptor in long receptor residence times.EBI
RhôNe-Poulenc Rorer
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: lead optimization.EBI
RhôNe-Poulenc Rorer
Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of pyrrolopiperidinone acetic acids as CRTh2 antagonists.EBI
RhôNe-Poulenc Rorer
2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists.EBI
RhôNe-Poulenc Rorer
2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists.EBI
RhôNe-Poulenc Rorer
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P1 direct agonists.EBI
RhôNe-Poulenc Rorer
Biaryl analogues of teriflunomide as potent DHODH inhibitors.EBI
RhôNe-Poulenc Rorer
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against EBI
Glaxosmithkline